| Literature DB >> 33727462 |
Vivek Mahendrapratap Singh1, Akshay Badakere1, Preeti Patil-Chhablani2, Ramesh Kekunnaya1.
Abstract
Purpose: To report the etiology, clinical presentation, and morphology of congenital cataract in a tertiary care center.Entities:
Keywords: Etiology; TORCH; infantile cataract; pediatric cataract surgery; rubella cataract
Year: 2021 PMID: 33727462 PMCID: PMC8012959 DOI: 10.4103/ijo.IJO_1558_20
Source DB: PubMed Journal: Indian J Ophthalmol ISSN: 0301-4738 Impact factor: 1.848
Questionnaire for history taking
| Standardized questionnaire for history: |
| Presenting complaints |
| Age of presentation |
| Onset, duration and course of the presenting complaints |
| Birth history (Vaginal delivery or cesarean section, full term or |
| pre-term, birth weight, history of incubation, history of jaundice, any other significant birth history) |
| General health, growth and developmental history |
| Immunization history |
| History of any exposure (treatments - medical or surgical, trauma, radiation, etc.) to both mother and the child |
| Maternal drug or infection history |
| History of any associated ocular or systemic feature. |
| Any significant family history (Pedigree charting) |
Congenital rubella syndrome (CRS) as per the definition given by the Centers for Disease Control and Prevention, 2015
| Congenital rubella syndrome (CRS) was diagnosed as per the definition given by the centers for Disease Control and Prevention, 2015. | |
| Clinical case definition | |
| An illness, usually manifesting in infancy, resulting from rubella infection in utero and characterized by clinical findings from the following categories | |
| a. Category A: Cataracts/congenital glaucoma, congenital heart disease (most commonly patent ductus arteriosus or peripheral pulmonary artery stenosis), hearing impairment, pigmentary retinopathy | |
| b. Category B: Purpura, hepatosplenomegaly, jaundice, microcephaly, developmental delay, meningoencephalitis, radiolucent bone disease | |
| Laboratory criteria (any one of the following) | |
| a. Isolation of rubella | |
| b. Demonstration of rubella-specific immunoglobulin M (IgM) | |
| c. Infant rubella antibody level (immunoglobulin G, IgG) that persists at a higher level and for a longer time than expected from passive transfer of maternal antibody (i.e., rubella titer that does not drop at the expected rate of a twofold dilution per month) | |
| Suspected CRS | An infant that does not meet the criteria for a probable or confirmed case but has one of more of the above clinical findings |
| Probable | An infant without an alternative etiology that does not have laboratory confirmation of rubella infection but has either: |
| At least two clinical findings from category A above, or | |
| One finding from category A and one or more from category B | |
| Confirmed | An infant with at least one of the above clinical findings that is clinically consistent with congenital rubella syndrome; and laboratory evidence of congenital rubella infection as demonstrated by any of the above laboratory criteria |
| Infection only | An infant without any clinical symptoms or signs but with laboratory evidence of infection as demonstrated by any of the above laboratory criteria |
Neonatal Herpes simplex virus infection as per the definition given by the Centers for Disease Control and Prevention, 2015
| Neonatal HSV was diagnosed on basis of positive IgM HSV antibody or HSV PCR positive. |
Laterality of cataract and relationship to etiology
| Laterality | Number of patients |
|---|---|
| Bilateral | |
| Hereditary | 19 (16.5%) |
| TORCH | 27 (24.7%) |
| Others | 15 (13.7%) |
| Idiopathic | 24 (22.0%) |
| Total | 85 (77.9%) |
| Unilateral | |
| Hereditary | 1 (0.9%) |
| TORCH | 10 (9.1%) |
| Others | 10 (9.1%) |
| Idiopathic | 3 (2.7%) |
| Total | 24 (22.1%) |
| Total | 109 |
Figure 1Various morphological variants of congenital cataract reported in the study. (a, d and g) total cataract, (b) child with Down syndrome and total cataract, (c) typical dirty yellow Rubella cataract, (e) asymmetrical cataract with exotropia, (f) Lamellar cataract, (l) Sutural cataract (h) Posterior lenticonus (Bilateral)
Various cataract morphologies and their aetiologies
| Morphology of cataract | Etiology | |
|---|---|---|
| Total cataract | Hereditary | 8 (7.3%) |
| TORCH | 17 (15.5%) | |
| Others | 9 (8.2%) | |
| Idiopathic | 13 (11.9%) | |
| Total | 47 (43.1%) | |
| Nuclear | Hereditary | 9 (8.2%) |
| TORCH | 17 (15.5%) | |
| Others | 9 (8.2%) | |
| Idiopathic | 12 (11.1%) | |
| Total | 47 (43.1%) | |
| PHPV | Total | 4 (3.6%) |
| Lamellar | Hereditary | 1 (0.9%) |
| TORCH | 1 (0.9%) | |
| ROP | 1 (0.9%) | |
| Idiopathic | 1 (0.9%) | |
| Total | 4 (3.6%) | |
| Anterior polar cataract | Anterior segment dysgenesis | 1 (0.9%) |
| TORCH | 1 (0.9%) | |
| Idiopathic | 1 (0.9%) | |
| Total | 3 (2.7%) | |
| Anterior capsular cataract | Smith-Lemli-opitz syndrome | 1 (0.9%) |
| Anterior sub-capsular cataract | Hereditary | 1 (0.9%) |
| Posterior sub-capsular cataract | TORCH | 1 (0.9%) |
| Cortical cataract | Hereditary | 1 (0.9%) |
Congenital cataract patients with TORCH infections and their laterality
| Etiology | Bilateral presentation | Unilateral presentation | Total |
|---|---|---|---|
| Rubella | |||
| Confirmed Congenital rubella syndrome | 8 (7.3%) | 6 (5.5%) | 14 (12.8%) |
| Probable Congenital rubella syndrome | 3 (2.7%) | 1 (0.9%) | 4 (3.6%) |
| Total | 11 (10.1%) | 7 (6.4%) | 18 (16.5%) |
| Cytomegalovirus | |||
| Congenital Cytomegalovirus | 6 (5.5%) | 1 (0.9%) | 7 (6.4%) |
| Possible Cytomegalovirus | 9 (8.2%) | 1 (0.9%) | 10 (9.1%) |
| Total | 15 (13.7%) | 2 (1.8%) | 17 (15.5%) |
| Neonatal Herpes simplex virus | 1 (0.9%) | 1 (0.9%) | 2 (1.8%) |
| Total | 27 (24.7%) | 10 (9.7%) | 37 (33.4%) |
Etiology of the patients with congenital cataract
| Etiology | Number of patients |
|---|---|
| Hereditary | |
| Autosomal dominant | 13 (11.9%) |
| Autosomal recessive | 7 (6.4%) |
| Total | 20 (18.3%) |
| TORCH | |
| Confirmed Congenital rubella syndrome | 14 (12.8%) |
| Probable Congenital rubella syndrome | 4 (3.6%) |
| Congenital Cytomegalovirus | 7 (6.4%) |
| Possible Cytomegalovirus | 10 (9.1%) |
| Neonatal Herpes simplex virus | 2 (1.8%) |
| Total | 37 (33.4%) |
| Metabolic | |
| Neonatal hypoglycemia | 2 (1.8%) |
| Hypercalcemia | 1 (0.9%) |
| Galactosemia | 1 (0.9%) |
| Total | 4 (3.6%) |
| Trauma | 19 (0.9%) |
| Developmental | |
| Posterior lenticonus | 5 (4.5%) |
| Persistent hyperplastic primary vitreous | 4 (3.6%) |
| Anterior segment dysgenesis | 2 (1.8%) |
| Total | 11 (10.1%) |
| Others | |
| Retinopathy of prematurity | 2 (1.8%) |
| Pierre Robin syndrome | 1 (0.9%) |
| Coats disease | 1 (0.9%) |
| Smith-Lemli-Opitz syndrome | 1 (0.9%) |
| Lowe syndrome | 1 (0.9%) |
| Warburg micro-syndrome | 1 (0.9%) |
| Cri-du-chat with muscular dystrophy | 1 (0.9%) |
| Down syndrome | 1 (0.9%) |
| Total | 9 (8.1%) |
| Idiopathic | 27 (24.7%) |
| Total | 109 |
Figure 2Bar diagram showing associated ocular features in patients with congenital cataract
Figure 3Bar diagram showing associated systemic features in patients with congenital cataract
Congenital Cytomegalovirus infection as per the definition given by the centers for Disease Control and Prevention, 2015
| Confirmed congenital CMV: |
| IgM CMV antibody positive |
| High titres of IgG CMV antibody - Although IgG beyond 3 weeks suggest passive transfer from mother. This usually starts decreasing from 3 months of age and completely disappears anywhere between 6 months to 12 months. High titres which are not decreasing beyond 3 months and are high for that respective age are considered to be significant. |
| Presence of 3 or more clinical signs of CMV: |
| Petechiae |
| Jaundice at birth |
| Hepatosplenomegaly |
| Short for age |
| Microcephaly |
| Sensorineural hearing loss |
| Hypotony |
| Failure to thrive |
| Seizures |
| Pneumonia |
| MRI findings: Periventricular calcifications, Periventricular leukomalacia, Ventriculomegaly, Polymicrogyria |
| Possible case of congenital CMV: |
| One or more signs of congenital CMV |
| Other caused have been excluded |
| High titres of CMV IgG after 3 weeks of life |